BioCentury
ARTICLE | Company News

Cancer Genetics sales and marketing update

June 22, 2015 7:00 AM UTC

Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Business: Diagnostic Cancer Genetics launched the Focus::Myeloid 54-biomarker panel in the U.S. to diagnose and determine prognosis for patients wi...